Workflow
三星医疗: 三星医疗关于变更回购股份用途并注销的公告

Core Viewpoint - The company plans to change the purpose of repurchased shares from employee stock ownership plans to cancellation and reduction of registered capital, involving 5,755,371 shares, which is approximately 0.41% of the total share capital [1][2][3]. Group 1: Share Repurchase Details - The company approved a share repurchase plan on December 7, 2023, with a total repurchase amount between RMB 150 million and RMB 300 million, at a price not exceeding RMB 21.00 per share [2]. - The company has completed the repurchase of shares at an average price of RMB 19.30 per share, totaling RMB 279,083,618.90, and has used 2,048,590 shares for its core team stock ownership plan [3]. Group 2: Purpose Change and Cancellation - The purpose of the repurchased shares is being changed to cancellation and reduction of registered capital, which will leave a balance of 5,755,371 shares in the repurchase account after the cancellation [3][5]. - Following the cancellation, the total share capital will decrease from 1,411,006,571 shares to 1,405,251,200 shares, and the registered capital will similarly decrease from RMB 1,411,006,571 to RMB 1,405,251,200 [1][4]. Group 3: Impact and Compliance - The change in the purpose of repurchased shares aligns with relevant laws and regulations, reflecting the company's confidence in future development and long-term value [5]. - This action is expected to optimize shareholder returns and enhance investor confidence without significantly impacting the company's financial status or operational capabilities [5].